Oren Gilad

CEO, Atrin Pharmaceuticals

Oren Gilad, Ph.D., is the president and CEO of Atrin Pharmaceuticals. He received his BA in Animal Science from the Hebrew University in Israel and his Ph.D. in Pathology from the University of California at Davis.

Oren is a dynamic scientific-entrepreneur and business leader who has built and profitably sold two small businesses. He is an innovator, strategic thinker, planner, and problem solver. He has leadership skills, proven execution skills, and extensive hands-on experience across the different phases of drug research and development and leadership. He has authored several high-impact scientific articles, the most recent demonstrating the importance of the ATR pathway in cancer development and prevention.

Oren's extensive cancer research over the last several years has furthered his desire to develop a company that will be able to take these new concepts and bring new successful therapies to help cancer patients of the world. Oren is a member of the Biotechnology Advisory Committee at Bucks County Community College and of the Entrepreneur Council Executive Committee of the Pennsylvania Biotechnology Center. He was recently named 2015 EY Entrepreneur Of The Year Greater Philadelphia Finalist in the Life Science category.


Share this: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

News for: Oren Gilad

Speaker at FiRe 2016

News Headlines
Atrin Pharmaceuticals Appoints Gerhard J. Sperl, Ph.D. as Vice President, Che...
Posted on 25 Oct 2016 at 5:34am

Atrin Pharmaceuticals Awarded $300,000 Phase 1 Contract for Development of Hi...
Posted on 19 Oct 2016 at 5:32am

Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD to Board of Directors
Posted on 16 Nov 2016 at 12:00am

SNS FiRe Conference Names Atrin Pharmaceutical a 2016 FiReStarter Company
Posted on 8 Jun 2016 at 5:00pm

"Entrepreneur Spotlight" Showcases PA Biotech Companies to Potential Investors
Posted on 25 Jul 2015 at 12:01am

Promises and perils at the Bleeding Edge of Healthcare
Posted on 29 Sep 2016 at 5:00pm

Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD to Board of Directors
Posted on 16 Nov 2016 at 12:01am



News feeds courtesy of:

FiRe 2016 Media


FiReStarters I: Six Companies Improving the World



Share this video: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

Bleeding-Edge Medicine: Today's Discoveries, Tomorrow's Practice



Share this video: Share on Facebook Tweet about this on Twitter Share on Google+ Share on LinkedIn Email this to someone

To contact Oren Gilad, fill out the form below.

iNews Mailroom (All fields required)
To:
From:
Your Email:
Subject:

Message: